title: Roles for T and NK cells in the innate immune response to Shigella flexneri.
abstract: Shigella flexneri, an enteroinvasive Gram-negative bacterium, is responsible for the worldwide endemic form of bacillary dysentery. The host response to primary infection is characterized by the induction of an acute inflammation, which is accompanied by polymorphonuclear cell (PMN) infiltration, resulting in massive destruction of the colonic mucosa. However, PMN play a major role in the recovery from primary infection, by restricting the bacterial infection at the intestinal mucosa. In this study, we assessed the roles for T and NK cells in the control of primary S. flexneri infection, using an alymphoid mouse strain (Rag null gamma(c) null) devoid of B, T, and NK cells. Using the mouse pulmonary model of Shigella infection, we showed that alymphoid Rag null gamma(c) null mice were highly susceptible to S. flexneri infection in comparison with wild-type (wt) mice. Whereas PMN recruitment upon infection was similar, macrophage recruitment and production of proinflammatory cytokines were significantly decreased in Rag null gamma(c) null mice compared with wt mice. Upon selective engraftment of Rag null gamma(c) null mice with polyclonal alphabeta T cells, but not with alphabeta T cells from IFN-gamma null , S. flexneri infection could be subsequently controlled. Rag null mice devoid of B and T cells but harboring NK cells could control infection. Local IFN-gamma production by T and NK cells recruited to the lung was demonstrated in S. flexneri-infected wt mice. These data demonstrate that both alphabeta T cells and NK cells contribute to the early control of S. flexneri infection through amplification of an inflammatory response. This cellular lymphocyte redundancy assures IFN-gamma production, which is central to innate immunity against Shigella infection.
authors: Unité des Cytokines et Développement Lymphoide, Institut National de la Santé et de la Recherche Médicale, Unité 668, Paris cedex, France.
authors: Karine
authors: K
authors: Le-Barillec
authors: Joao Gamelas
authors: JG
authors: Magalhaes
authors: Erwan
authors: E
authors: Corcuff
authors: Audrey
authors: A
authors: Thuizat
authors: Philippe J
authors: PJ
authors: Sansonetti
authors: Armelle
authors: A
authors: Phalipon
authors: James P
authors: JP
authors: Di Santo
mesh_terms: D000818:Animals; D004268:DNA-Binding Proteins / Q000172:deficiency / Q000235:genetics; D004405:Dysentery, Bacillary / Q000235:genetics / Q000276:immunology* / Q000517:prevention & control; D020022:Genetic Predisposition to Disease; D018398:Homeodomain Proteins / Q000235:genetics; D007113:Immunity, Innate / Q000235:genetics; D018836:Inflammation Mediators / Q000502:physiology; D007371:Interferon-gamma / Q000096:biosynthesis; D053631:Interleukin Receptor Common gamma Subunit; D007413:Intestinal Mucosa / Q000276:immunology / Q000378:metabolism / Q000382:microbiology / Q000473:pathology; D007694:Killer Cells, Natural / Q000276:immunology* / Q000378:metabolism; D008168:Lung / Q000276:immunology / Q000378:metabolism / Q000382:microbiology / Q000473:pathology; D051379:Mice; D008810:Mice, Inbred C57BL; D018345:Mice, Knockout; D016693:Receptors, Antigen, T-Cell, alpha-beta / Q000008:administration & dosage / Q000276:immunology; D020395:Receptors, Interleukin-7 / Q000172:deficiency / Q000235:genetics; D012763:Shigella flexneri / Q000276:immunology*; D016176:T-Lymphocyte Subsets / Q000276:immunology* / Q000378:metabolism / Q000637:transplantation
chemical_list: D004268:DNA-Binding Proteins; D018398:Homeodomain Proteins; C507942:Il2rg protein, mouse; D018836:Inflammation Mediators; D053631:Interleukin Receptor Common gamma Subunit; C499308:Rag2 protein, mouse; D016693:Receptors, Antigen, T-Cell, alpha-beta; D020395:Receptors, Interleukin-7; C064655:V(D)J recombination activating protein 2; C064658:RAG-1 protein; D007371:Interferon-gamma